CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 10, 2004--Alkermes, Inc. (NASDAQ: ALKS) announced today that its Analyst and Investor Day presentations will be webcast live on the investor relations section of its website at www.alkermes.com.
Alkermes senior management will review the Company's business strategy, drug development operations and pipeline progress. The presentations will be delivered on Monday, May 17, 2004 beginning at approximately 12:20pm EDT and ending at 3:45pm EDT from The W Hotel, 541 Lexington Avenue, New York. For more information or to attend this event, please contact Debra Koufos at (617) 583-6220. This webcast will be archived for 14 days.
Alkermes, Inc. is an emerging pharmaceutical company developing products based on its sophisticated drug delivery technologies to enhance therapeutic outcomes. Our areas of focus include: controlled, extended-release of injectable drugs utilizing our ProLease(R) and Medisorb(R) delivery systems and the development of inhaled pharmaceutical products based on our proprietary AIR(R) pulmonary delivery system. Our business strategy is twofold. We partner our proprietary technology systems and drug delivery expertise with many of the world's finest pharmaceutical companies and also develop novel, proprietary drug candidates for our own account. In addition to our Cambridge, Massachusetts headquarters and research and manufacturing facilities, we operate research and manufacturing facilities in Ohio.
CONTACT: Alkermes, Inc.
Rebecca Peterson, 617-583-6378
Director, Corporate Communications
SOURCE: Alkermes, Inc.